The current price of WVE is $3.22 — it has decreased by 11.05% since the previous close. Data as of Nov 5, 2026.
WVE is down 11.05% over the past week, down 14.13% over the past month and down 59.95% over the past year. The price is below its 200-day moving average of $7.27.
Analysts' average 12-month price target for WVE is $12.33, which implies 282.92% upside from the current price. Individual estimates range from $10.00 to $14.00.
Of the 21 analysts covering Wave Life Sciences Ltd., 2 rate it a strong buy, 17 rate it a buy and 2 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Wave Life Sciences Ltd. has a market capitalization of $635.08M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Wave Life Sciences Ltd. posted a loss of $0.30 per share against an estimate of -$0.329, beating expectations by 8.83%. Upcoming reports are listed in the earnings calendar.
Wave Life Sciences Ltd. reported revenue of $13.16M in its most recent quarter, which has increased by 72.95% compared with the same quarter a year earlier. Analysts had expected $4.51M.
Wave Life Sciences Ltd. has not paid any dividends over the past year.
Companies most comparable to Wave Life Sciences Ltd. include Alnylam Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Sarepta Therapeutics, Inc. and Stoke Therapeutics, Inc.
In the latest trading session WVE moved between $3.18 and $3.62, a range of 13.51% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Wave Life Sciences Ltd. shows a strong sell rating today. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Wave Life Sciences Ltd. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks WVE has traded between $3.04 and $21.73. The current price is 85.18% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.